Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.
Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.
复制标题
尽管甲基苯丙胺诱导部分多巴胺去神经,但内侧前脑束的阶段性刺激增强了纹状体基因表达。
DOI:
10.1111/jnc.12234
复制
发表时间:
2013
影响因子:
4.7
通讯作者:
Keefe,KristenA
中科院分区:
文献类型:
--
作者:
Howard,ChristopherD;Pastuzyn,ElissaD;Barker-Haliski,MelissaL;Garris,PaulA;Keefe,KristenA
Methamphetamine‐induced partial dopamine depletions are associated with impaired basal ganglia function, including decreasedpreprotachykininmRNA expression and impaired transcriptional activation of activity‐regulated, cytoskeleton‐associated (Arc) gene in striatum. Recent work implicates deficits in phasic dopamine signaling as a potential mechanism linking methamphetamine‐induced dopamine loss to impaired basal ganglia function. This study thus sought to establish a causal link between phasic dopamine transmission and altered basal ganglia function by determining whether the deficits in striatal neuron gene expression could be restored by increasing phasic dopamine release. Three weeks after pretreatment with saline or a neurotoxic regimen of methamphetamine, rats underwent phasic‐ or tonic‐like stimulation of ascending dopamine neurons. Striatal gene expression was examined usingin situhybridization histochemistry. Phasic‐like, but not tonic‐like, stimulation induced immediate‐early genesArcandzif268in both groups, despite the partial striatal dopamine denervation in methamphetamine‐pretreated rats, with theArcexpression occurring in presumed striatonigral efferent neurons. Phasic‐like stimulation also restoredpreprotachykininmRNA expression. These results suggest that disruption of phasic dopamine signaling likely underlies methamphetamine‐induced impairments in basal ganglia function, and that restoring phasic dopamine signaling may be a viable approach to manage long‐term consequences of methamphetamine‐induced dopamine loss on basal ganglia functions.